BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30240696)

  • 1. Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition.
    Liu YR; Sun B; Zhu GH; Li WW; Tian YX; Wang LM; Zong SM; Sheng PZ; Li M; Chen S; Qin Y; Liu HJ; Zhou HG; Sun T; Yang C
    Toxicol Appl Pharmacol; 2018 Dec; 360():1-8. PubMed ID: 30240696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium-enriched polysaccharides from Pyracantha fortuneana (Se-PFPs) inhibit the growth and invasive potential of ovarian cancer cells through inhibiting β-catenin signaling.
    Sun Q; Dong M; Wang Z; Wang C; Sheng D; Li Z; Huang D; Yuan C
    Oncotarget; 2016 May; 7(19):28369-83. PubMed ID: 27058760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
    Markov AV; Odarenko KV; Sen'kova AV; Salomatina OV; Salakhutdinov NF; Zenkova MA
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33327637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition.
    Feng B; Zhu Y; Sun C; Su Z; Tang L; Li C; Zheng G
    Int J Biol Macromol; 2019 Sep; 137():32-44. PubMed ID: 31252022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells.
    Lin S; Lyu X; Yu J; Sun L; Du D; Lai Y; Li H; Wang Y; Zhang L; Yin H; Yuan S
    Phytomedicine; 2016 Sep; 23(10):1053-63. PubMed ID: 27444351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition on the growth of human MDA-MB-231 breast cancer cells in vitro and tumor growth in a mouse xenograft model by Se-containing polysaccharides from Pyracantha fortuneana.
    Yuan C; Wang C; Wang J; Kumar V; Anwar F; Xiao F; Mushtaq G; Liu Y; Kamal MA; Yuan D
    Nutr Res; 2016 Nov; 36(11):1243-1254. PubMed ID: 27865619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of selenium nanoparticles/β-glucan composites for enhancement of the antitumor activity.
    Jia X; Liu Q; Zou S; Xu X; Zhang L
    Carbohydr Polym; 2015 Mar; 117():434-442. PubMed ID: 25498656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chitosan oligosaccharide-conjugated selenium on improving immune function and blocking gastric cancer growth.
    Jiang Z; Chi J; Li H; Wang Y; Liu W; Han B
    Eur J Pharmacol; 2021 Jan; 891():173673. PubMed ID: 33098836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HP-1 inhibits the progression of ccRCC and enhances sunitinib therapeutic effects by suppressing EMT.
    Fang L; Zhang Y; Zang Y; Chai R; Zhong G; Li Z; Duan Z; Ren J; Xu Z
    Carbohydr Polym; 2019 Nov; 223():115109. PubMed ID: 31427001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium-containing polysaccharides from Lentinula edodes-Biological activity.
    Kaleta B; Górski A; Zagożdżon R; Cieślak M; Kaźmierczak-Barańska J; Nawrot B; Klimaszewska M; Malinowska E; Górska S; Turło J
    Carbohydr Polym; 2019 Nov; 223():115078. PubMed ID: 31427018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
    Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
    Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentinan Attenuated the PM2.5 Exposure-Induced Inflammatory Response, Epithelial-Mesenchymal Transition and Migration by Inhibiting the PVT1/miR-199a-5p/caveolin1 Pathway in Lung Cancer.
    Qi H; Liu Y; Wang N; Xiao C
    DNA Cell Biol; 2021 May; 40(5):683-693. PubMed ID: 33902331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis.
    Qi HW; Xin LY; Xu X; Ji XX; Fan LH
    J Transl Med; 2014 Jan; 12():22. PubMed ID: 24456611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner.
    Hu H; Dong Z; Tan P; Zhang Y; Liu L; Yang L; Liu Y; Cui H
    Oncotarget; 2016 Jan; 7(3):3171-85. PubMed ID: 26621850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1.
    Liu Y; Cheng DH; Lai KD; Su H; Lu GS; Wang L; Lv JH
    Drug Des Devel Ther; 2021; 15():4885-4899. PubMed ID: 34880599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
    Zhao J; Zhang Q; Zou G; Gao G; Yue Q
    J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway.
    Liu HJ; Qin Y; Zhao ZH; Zhang Y; Yang JH; Zhai DH; Cui F; Luo C; Lu MX; Liu PP; Xu HW; Li K; Sun B; Chen S; Zhou HG; Yang C; Sun T
    Theranostics; 2020; 10(20):9083-9099. PubMed ID: 32802180
    [No Abstract]   [Full Text] [Related]  

  • 20. Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer.
    Li X; Zhou Y; Liu Y; Zhang X; Chen T; Chen K; Ba Q; Li J; Liu H; Wang H
    EBioMedicine; 2016 Dec; 14():44-54. PubMed ID: 27939426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.